GlassScriptPhysician profile
Steven C Johnson
NPI 1679581581
$3,674.57
in general payments reported to CMS, 2019-2025
13 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,337 · 2020: $218 · 2021: $11.60 · 2022: $552 · 2023: $1,025 · 2024: $126 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,538 · Education: $17.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,538.29 |
| Education | $17.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,329.70 | 2019-2025 | Clareon, Ngenuity, Constellation |
| Abbvie INC. | $423.25 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $267.61 | 2022-2025 | Eylea, Eylea Hd |
| Genentech USA, INC. | $219.90 | 2020-2024 | Vabysmo |
| Glaukos Corporation | $174.83 | 2022-2023 | Photrexa Cross-Linking Kit |
| Allergan, INC. | $86.23 | 2020 | |
| Apellis Pharmaceuticals, INC. | $47.94 | 2023 | Syfovre |
| Rayner Intraocular Lenses Limited | $33.71 | 2023 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Alimera Sciences, INC. | $21.52 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $19.24 | 2023 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $17.39 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.